$1.78 Billion is the total value of NEA Management Company, LLC's 57 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 17.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COUR | COURSERA INC | $187,715,707 | +9.7% | 15,867,769 | 0.0% | 10.55% | +23.6% | |
| Sell | ARCELLX INC | $147,008,217 | +16.0% | 4,745,262 | -29.7% | 8.26% | +30.6% | |
| VRNA | VERONA PHARMA PLCsponsered ads | $145,929,596 | +155.7% | 5,584,753 | 0.0% | 8.20% | +187.9% | |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $142,977,919 | +32.0% | 4,909,956 | -0.0% | 8.04% | +48.6% |
| BHG | Sell | BRIGHT HEALTH GROUP INC | $141,778,040 | -38.1% | 218,153,623 | -0.0% | 7.97% | -30.3% |
| NET | Sell | CLOUDFLARE INC | $84,715,538 | -18.4% | 1,873,823 | -0.2% | 4.76% | -8.1% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $81,631,739 | -7.2% | 4,186,243 | -0.0% | 4.59% | +4.4% |
| Sell | ZEROFOX HLDGS INC | $80,983,075 | -8.3% | 18,068,513 | -0.1% | 4.55% | +3.3% | |
| OYST | OYSTER PT PHARMA INC | $66,185,456 | +98.8% | 5,925,287 | 0.0% | 3.72% | +123.8% | |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $64,546,265 | -37.9% | 1,587,854 | -0.1% | 3.63% | -30.1% |
| GLUE | Sell | MONTE ROSA THERAPEUTICS INC | $58,538,388 | -7.0% | 7,692,298 | -0.1% | 3.29% | +4.7% |
| ALLK | Sell | ALLAKOS INC | $51,759,929 | +52.8% | 6,147,260 | -0.0% | 2.91% | +72.1% |
| Sell | IONQ INC | $50,421,160 | -62.3% | 14,614,829 | -44.5% | 2.83% | -57.5% | |
| CVRX | Sell | CVRX INC | $43,499,446 | +96.7% | 2,370,542 | -0.0% | 2.44% | +121.4% |
| GERN | GERON CORP | $39,491,208 | +3.4% | 16,318,681 | 0.0% | 2.22% | +16.4% | |
| SVRA | SAVARA INC | $37,413,793 | -0.0% | 24,137,931 | 0.0% | 2.10% | +12.6% | |
| GLYC | Sell | GLYCOMIMETICS INC | $27,172,149 | +441.9% | 8,967,706 | -1.3% | 1.53% | +510.8% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $24,936,476 | +35.8% | 17,079,779 | -0.0% | 1.40% | +52.8% |
| NEXTNAV INC | $23,994,227 | +8.9% | 8,189,156 | 0.0% | 1.35% | +22.5% | ||
| Sell | BERKSHIRE GREY INC | $23,058,728 | -64.5% | 38,183,023 | -0.1% | 1.30% | -60.0% | |
| CTIC | CTI BIOPHARMA CORP | $22,150,955 | +3.3% | 3,685,683 | 0.0% | 1.24% | +16.2% | |
| TRVI | TREVI THERAPEUTICS INC | $21,950,226 | +25.3% | 11,373,174 | 0.0% | 1.23% | +41.2% | |
| NKTX | Sell | NKARTA INC | $21,376,998 | -54.5% | 3,568,781 | -0.1% | 1.20% | -48.8% |
| DM | Sell | DESKTOP METAL INC | $19,582,541 | -47.5% | 14,398,927 | -0.1% | 1.10% | -41.0% |
| CELC | New | CELCUITY INC | $17,512,514 | – | 1,250,001 | +100.0% | 0.98% | – |
| AUPH | AURINIA PHARMACEUTICALS INC | $17,149,683 | -42.6% | 3,969,834 | 0.0% | 0.96% | -35.3% | |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $11,654,635 | +4.5% | 11,736,793 | +79.9% | 0.66% | +17.6% |
| RPHM | Sell | RENEO PHARMACEUTICALS INC | $11,150,201 | -30.5% | 4,785,494 | -0.0% | 0.63% | -21.6% |
| BUZZFEED INC | $10,574,252 | -55.8% | 15,333,892 | 0.0% | 0.59% | -50.3% | ||
| FISCALNOTE HOLDINGS INC | $9,652,558 | +11.8% | 1,694,323 | 0.0% | 0.54% | +25.8% | ||
| TUYA | TUYA INCsponsered ads | $9,425,162 | +105.4% | 4,934,640 | 0.0% | 0.53% | +131.4% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $7,728,877 | -39.9% | 1,713,720 | 0.0% | 0.43% | -32.4% | |
| GOSS | GOSSAMER BIO INC | $7,524,271 | -81.9% | 3,467,406 | 0.0% | 0.42% | -79.6% | |
| IVA | Sell | INVENTIVA SAads | $7,004,324 | -64.8% | 1,462,586 | -73.8% | 0.39% | -60.4% |
| BILL | Sell | BILL COM HLDGS INC | $6,839,038 | -17.7% | 66,070 | -0.0% | 0.38% | -7.5% |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS INC | $6,207,763 | +6.5% | 3,448,757 | -0.0% | 0.35% | +19.9% |
| AFMD | AFFIMED NV | $5,488,845 | -39.8% | 4,426,488 | 0.0% | 0.31% | -32.3% | |
| Sell | SENTI BIOSCIENCES INC | $5,345,198 | -35.1% | 4,426,151 | -0.1% | 0.30% | -27.0% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $4,550,166 | -20.4% | 2,382,286 | 0.0% | 0.26% | -10.2% | |
| New | ACRIVON THERAPEUTICS INC | $4,439,135 | – | 481,677 | +100.0% | 0.25% | – | |
| XERIS BIOPHARMA HOLDINGS INC | $4,318,224 | -14.7% | 3,246,785 | 0.0% | 0.24% | -4.0% | ||
| SYBX | Sell | SYNLOGIC INC | $3,213,994 | -20.0% | 4,228,940 | -0.0% | 0.18% | -10.0% |
| MRKR | MARKER THERAPEUTICS INC | $2,848,918 | -27.9% | 10,714,285 | 0.0% | 0.16% | -18.8% | |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $2,693,662 | -85.7% | 2,992,958 | -4.8% | 0.15% | -84.0% |
| EAR | Sell | EARGO INC | $2,599,114 | -45.2% | 4,520,198 | -0.0% | 0.15% | -38.4% |
| INZY | Sell | INOZYME PHARMA INC | $2,559,573 | -60.9% | 2,437,689 | -0.3% | 0.14% | -56.0% |
| Sell | MINERVA SURGICAL INC | $2,233,805 | -71.9% | 9,999,125 | -0.0% | 0.13% | -68.3% | |
| MEIP | MEI PHARMA INC | $2,078,656 | -37.0% | 8,533,072 | 0.0% | 0.12% | -29.1% | |
| RGLS | Sell | REGULUS THERAPEUTICS INC | $1,979,806 | -19.4% | 1,445,114 | -0.0% | 0.11% | -9.8% |
| Sell | AIRSPAN NETWORKS HOLDINGS INC | $1,810,813 | -41.6% | 1,382,300 | -9.9% | 0.10% | -34.2% | |
| UP | WHEELS UP EXPERIENCE INC | $1,093,097 | -10.4% | 1,061,259 | 0.0% | 0.06% | 0.0% | |
| OBSV | OBSEVA SA | $665,052 | +2.0% | 4,586,563 | 0.0% | 0.04% | +12.1% | |
| AKTX | AKARI THERAPEUTICS PLCsponsored adr | $212,473 | -25.4% | 452,167 | 0.0% | 0.01% | -14.3% | |
| ADXN | Sell | ADDEX THERAPEUTICS LTDsponsored ads | $113,418 | -86.3% | 1,080,000 | -80.9% | 0.01% | -85.4% |
| New | AIRSPAN NETWORKS HOLDINGS INC*w exp 08/13/2023 | $110 | – | 69,928 | +100.0% | 0.00% | – | |
| New | AIRSPAN NETWORKS HOLDINGS INC*w exp 08/13/2023 | $61 | – | 69,928 | +100.0% | 0.00% | – | |
| New | AIRSPAN NETWORKS HOLDINGS INC*w exp 08/13/2023 | $212 | – | 69,928 | +100.0% | 0.00% | – | |
| PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -141 | -100.0% | -0.00% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -346,719 | -100.0% | -0.03% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -6,643,702 | -100.0% | -0.06% | – |
| AKUS | Exit | AKOUOS INC | $0 | – | -4,298,488 | -100.0% | -1.45% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -3,952,957 | -100.0% | -1.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.